Source:-┬аhindustantimes.com Around 2.1 million people have TB in India, of which an estimated 30,000 people have MDR-TB. Only 6,500 patients are on the bedaquiline-based treatment regimen, which may cause severe side effects such as heart problems and hearing impairment. The Union health ministry is considering a proposal to allow bedaquiline, a controlled-access drug used in